Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Warminster, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Arbutus Biopharma Corp has filed 1,026 SEC EDGAR filings since 30 Sep 2008

SEC filing history

Showing 526-550 of 1,000 matching filings.

Per page
25
Current page
22
3

OWNERSHIP DOCUMENT

Filing date
10 Jul 2017
Reporting date
01 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-85963

SC 13D/A filing

Filing date
06 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jun 2017
Reporting date
21 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jun 2017
Reporting date
21 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Jun 2017
Reporting date
21 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Jun 2017
Reporting date
21 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Jun 2017
Reporting date
21 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Jun 2017
Reporting date
21 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-85963

SC 13D/A filing

Filing date
14 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-34949

CT ORDER filing

Filing date
09 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34949

FORM 8-K

Filing date
02 Jun 2017
Reporting date
02 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34949

8-K filing

Filing date
26 May 2017
Reporting date
24 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34949

FORM 8-K

Filing date
22 May 2017
Reporting date
22 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85963

SC 13G filing

Filing date
17 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-34949

10-K/A

Filing date
17 May 2017
Reporting date
31 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-34949

10-Q Q1 2017 ARBUTUS BIOPHARMA CORP

Filing date
04 May 2017
Reporting date
31 Mar 2017
Next action
Verify source filing
8-K File 001-34949

FORM 8-K

Filing date
04 May 2017
Reporting date
04 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34949

FORM 8-K

Filing date
02 May 2017
Reporting date
02 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34949

FORM 8-K

Filing date
25 Apr 2017
Reporting date
22 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-34949

DEFA14A NOTIFICATION OF AVAILABILITY 2017

Filing date
18 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-34949

DEF 14A PROXY MAY 2017

Filing date
18 Apr 2017
Reporting date
18 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34949

FORM 8-K

Filing date
13 Apr 2017
Reporting date
13 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .